Symbols / BMY Stock $58.80 -0.99% Bristol-Myers Squibb Company

Healthcare • Drug Manufacturers - General • United States • NYQ
BMY (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, and to a lesser extent, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

Stock Fundamentals
Scroll to Statements
Market Cap 120.05B Enterprise Value 156.29B Income 7.05B Sales 48.19B Book/sh 9.07 Cash/sh 5.24
Dividend Yield 4.29% Payout 71.97% Employees 32500 IPO — P/E 16.99 Forward P/E 9.58
PEG 23.65 P/S 2.49 P/B 6.48 P/C — EV/EBITDA 8.18 EV/Sales 3.24
Quick Ratio 1.08 Current Ratio 1.25 Debt/Eq 254.98 LT Debt/Eq — EPS (ttm) 3.46 EPS next Y 6.14
EPS Growth 13.92% Revenue Growth 1.30% Earnings 2026-04-30 ROA 10.29% ROE 40.44% ROIC —
Gross Margin 72.62% Oper. Margin 28.16% Profit Margin 14.64% Shs Outstand 2.04B Shs Float 2.03B Short Float 1.54%
Short Ratio 2.29 Short Interest — 52W High 62.89 52W Low 42.52 Beta 0.27 Avg Volume 12.63M
Volume 7.50M Target Price $63.04 Recom Hold Prev Close $59.39 Price $58.80 Change -0.99%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$63.04
Mean price target
2. Current target
$58.80
Latest analyst target
3. DCF / Fair value
$98.27
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$58.80
Low
$40.00
High
$75.00
Mean
$63.04

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-09 main B of A Securities Buy → Buy $67
2026-04-08 reit Guggenheim Buy → Buy $72
2026-04-08 main Cantor Fitzgerald Neutral → Neutral $54
2026-03-17 main HSBC Hold → Hold $60
2026-02-25 init RBC Capital — → Sector Perform $60
2026-02-23 main Piper Sandler Overweight → Overweight $75
2026-02-20 init Barclays — → Overweight $75
2026-02-06 main Citigroup Neutral → Neutral $64
2026-02-06 main Wells Fargo Equal-Weight → Equal-Weight $60
2026-02-06 main Guggenheim Buy → Buy $72
2026-01-28 main Piper Sandler Overweight → Overweight $66
2026-01-27 main Citigroup Neutral → Neutral $60
2026-01-13 main Leerink Partners Outperform → Outperform $60
2026-01-09 main Scotiabank Sector Perform → Sector Perform $60
2026-01-07 main Citigroup Neutral → Neutral $53
2026-01-07 up UBS Neutral → Buy $65
2025-12-15 up B of A Securities Neutral → Buy $61
2025-12-12 main Morgan Stanley Underweight → Underweight $37
2025-12-12 up Guggenheim Neutral → Buy $62
2025-12-10 main Wells Fargo Equal-Weight → Equal-Weight $55
News
RSS: Latest BMY news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 SHANAHAN KARIN Officer — 3,307 — —
2026-04-01 ELKINS DAVID VINCENT Chief Financial Officer — 30,000 $61.60 $1,850,016
2026-03-10 PLENGE ROBERT M Officer — 17,501 — —
2026-03-10 MEYERS GREGORY SCOTT Chief Technology Officer — 25,892 — —
2026-03-10 SHANAHAN KARIN Officer — 25,501 — —
2026-03-10 LENKOWSKY ADAM Officer — 24,071 — —
2026-03-10 GALLMAN CARI General Counsel — 6,980 — —
2026-03-10 HOCH LYNELLE BAUMGARDNER Officer — 8,192 — —
2026-03-10 POOLE AHN AMANDA Officer — 6,436 — —
2026-03-10 HOLZER PHIL M Officer — 6,191 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
48,195.00
-0.22%
48,300.00
+7.32%
45,006.00
-2.50%
46,159.00
Operating Revenue
47,203.00
-0.11%
47,257.00
+6.47%
44,386.00
-2.26%
45,413.00
Cost Of Revenue
13,936.00
-0.23%
13,968.00
+30.63%
10,693.00
+5.48%
10,137.00
Reconciled Cost Of Revenue
13,242.00
+0.02%
13,240.00
+32.67%
9,980.00
+5.54%
9,456.00
Gross Profit
34,259.00
-0.21%
34,332.00
+0.06%
34,313.00
-4.74%
36,022.00
Operating Expense
20,535.00
-27.81%
28,445.00
+8.91%
26,118.00
-2.97%
26,918.00
Research And Development
9,951.00
-10.83%
11,159.00
+20.00%
9,299.00
-2.21%
9,509.00
Selling General And Administration
7,267.00
-13.63%
8,414.00
+8.26%
7,772.00
-0.54%
7,814.00
Selling And Marketing Expense
—
—
—
7,814.00
General And Administrative Expense
—
—
—
7,814.00
Salaries And Wages
—
—
—
—
Other Gand A
—
—
—
7,814.00
Total Expenses
34,471.00
-18.73%
42,413.00
+15.22%
36,811.00
-0.66%
37,055.00
Operating Income
13,724.00
+133.12%
5,887.00
-28.16%
8,195.00
-9.98%
9,104.00
EBITDA
15,230.00
+380.74%
3,168.00
-83.64%
19,366.00
+0.75%
19,221.00
Normalized EBITDA
19,945.00
+16.64%
17,100.00
-15.51%
20,239.00
-5.49%
21,414.00
Reconciled Depreciation
4,011.00
-58.22%
9,600.00
-1.64%
9,760.00
-5.02%
10,276.00
EBIT
11,219.00
+274.42%
-6,432.00
-166.96%
9,606.00
+7.39%
8,945.00
Total Unusual Items
-4,715.00
+66.16%
-13,932.00
-1495.88%
-873.00
+60.19%
-2,193.00
Total Unusual Items Excluding Goodwill
-4,715.00
+66.16%
-13,932.00
-1495.88%
-873.00
+60.19%
-2,193.00
Special Income Charges
-5,225.00
+63.78%
-14,426.00
-1141.48%
-1,162.00
+25.66%
-1,563.00
Other Special Charges
434.00
+416.67%
84.00
+121.54%
-390.00
-187.84%
444.00
Impairment Of Capital Assets
—
47.00
+62.07%
29.00
0.00
Restructuring And Mergern Acquisition
4,791.00
-66.59%
14,342.00
+824.10%
1,552.00
+16.69%
1,330.00
Net Income
7,054.00
+178.83%
-8,948.00
-211.50%
8,025.00
+26.84%
6,327.00
Pretax Income
9,328.00
+211.33%
-8,379.00
-199.28%
8,440.00
+9.43%
7,713.00
Net Non Operating Interest Income Expense
-1,891.00
+2.88%
-1,947.00
-66.98%
-1,166.00
+5.36%
-1,232.00
Interest Expense Non Operating
1,891.00
-2.88%
1,947.00
+66.98%
1,166.00
-5.36%
1,232.00
Net Interest Income
-1,891.00
+2.88%
-1,947.00
-66.98%
-1,166.00
+5.36%
-1,232.00
Interest Expense
1,891.00
-2.88%
1,947.00
+66.98%
1,166.00
-5.36%
1,232.00
Other Income Expense
-2,504.00
+79.67%
-12,319.00
-973.07%
1,411.00
+987.42%
-159.00
Other Non Operating Income Expenses
2,211.00
+37.07%
1,613.00
-29.38%
2,284.00
+12.29%
2,034.00
Gain On Sale Of Security
510.00
+3.24%
494.00
+70.93%
289.00
+145.87%
-630.00
Gain On Sale Of Business
—
-15.00
0.00
-100.00%
211.00
Tax Provision
2,272.00
+310.11%
554.00
+38.50%
400.00
-70.76%
1,368.00
Tax Rate For Calcs
0.00
+15.98%
0.00
+346.81%
0.00
-73.45%
0.00
Tax Effect Of Unusual Items
-1,148.42
+60.75%
-2,925.72
-7030.51%
-41.03
+89.43%
-388.16
Net Income Including Noncontrolling Interests
7,055.00
+178.98%
-8,933.00
-211.11%
8,040.00
+26.71%
6,345.00
Net Income From Continuing Operation Net Minority Interest
7,054.00
+178.83%
-8,948.00
-211.50%
8,025.00
+26.84%
6,327.00
Net Income From Continuing And Discontinued Operation
7,054.00
+178.83%
-8,948.00
-211.50%
8,025.00
+26.84%
6,327.00
Net Income Continuous Operations
7,055.00
+178.98%
-8,933.00
-211.11%
8,040.00
+26.71%
6,345.00
Minority Interests
-2.00
+86.67%
-15.00
+0.00%
-15.00
+16.67%
-18.00
Normalized Income
10,620.58
+415.99%
2,058.28
-76.76%
8,856.97
+8.92%
8,131.84
Net Income Common Stockholders
7,054.00
+178.83%
-8,948.00
-211.50%
8,025.00
+26.84%
6,327.00
Diluted EPS
3.46
+178.46%
-4.41
-214.25%
3.86
+30.85%
2.95
Basic EPS
3.47
+178.68%
-4.41
-213.66%
3.88
+30.64%
2.97
Basic Average Shares
2,034.00
+0.35%
2,027.00
-2.03%
2,069.00
-2.86%
2,130.00
Diluted Average Shares
2,039.00
+0.59%
2,027.00
-2.45%
2,078.00
-3.17%
2,146.00
Diluted NI Availto Com Stockholders
7,054.00
+178.83%
-8,948.00
-211.50%
8,025.00
+26.84%
6,327.00
Amortization
3,317.00
-62.61%
8,872.00
-1.93%
9,047.00
-5.71%
9,595.00
Amortization Of Intangibles Income Statement
3,317.00
-62.61%
8,872.00
-1.93%
9,047.00
-5.71%
9,595.00
Depreciation Amortization Depletion Income Statement
3,317.00
-62.61%
8,872.00
-1.93%
9,047.00
-5.71%
9,595.00
Depreciation And Amortization In Income Statement
3,317.00
-62.61%
8,872.00
-1.93%
9,047.00
-5.71%
9,595.00
Earnings From Equity Interest
—
—
-160.00
+80.02%
-801.00
Other Taxes
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
90,038.00
-2.77%
92,603.00
-2.69%
95,159.00
-1.72%
96,820.00
Current Assets
29,390.00
-1.31%
29,780.00
-6.26%
31,770.00
+16.49%
27,273.00
Cash Cash Equivalents And Short Term Investments
10,673.00
-1.71%
10,859.00
-11.57%
12,280.00
+32.71%
9,253.00
Cash And Cash Equivalents
10,209.00
-1.32%
10,346.00
-9.75%
11,464.00
+25.66%
9,123.00
Other Short Term Investments
464.00
-9.55%
513.00
-37.13%
816.00
+527.69%
130.00
Receivables
14,525.00
+0.70%
14,424.00
-5.50%
15,264.00
+9.52%
13,937.00
Accounts Receivable
9,592.00
+6.44%
9,012.00
+1.46%
8,882.00
+8.97%
8,151.00
Gross Accounts Receivable
11,370.00
+14.19%
9,957.00
+4.25%
9,551.00
+7.95%
8,848.00
Allowance For Doubtful Accounts Receivable
-1,778.00
-88.15%
-945.00
-41.26%
-669.00
+4.02%
-697.00
Other Receivables
2,013.00
-5.05%
2,120.00
-13.65%
2,455.00
+9.65%
2,239.00
Taxes Receivable
2,920.00
-11.30%
3,292.00
-16.17%
3,927.00
+10.71%
3,547.00
Inventory
2,690.00
+5.20%
2,557.00
-3.94%
2,662.00
+13.81%
2,339.00
Raw Materials
—
—
—
464.00
Work In Process
—
—
—
1,850.00
Finished Goods
—
—
—
509.00
Restricted Cash
—
0.00
-100.00%
55.00
-62.84%
148.00
Other Current Assets
1,502.00
-22.58%
1,940.00
+28.56%
1,509.00
-5.45%
1,596.00
Total Non Current Assets
60,648.00
-3.46%
62,823.00
-0.89%
63,389.00
-8.85%
69,547.00
Net PPE
9,125.00
+9.15%
8,360.00
+4.03%
8,036.00
+7.51%
7,475.00
Gross PPE
14,418.00
+8.33%
13,309.00
+3.66%
12,839.00
+10.31%
11,639.00
Accumulated Depreciation
-5,293.00
-6.95%
-4,949.00
-3.04%
-4,803.00
-15.35%
-4,164.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
157.00
-2.48%
161.00
-0.62%
162.00
+0.00%
162.00
Buildings And Improvements
7,270.00
+10.47%
6,581.00
+1.32%
6,495.00
+9.71%
5,920.00
Machinery Furniture Equipment
3,790.00
-0.73%
3,818.00
+2.72%
3,717.00
+13.19%
3,284.00
Construction In Progress
1,619.00
+6.16%
1,525.00
+41.86%
1,075.00
+2.09%
1,053.00
Other Properties
1,582.00
+29.25%
1,224.00
-11.94%
1,390.00
+13.93%
1,220.00
Goodwill And Other Intangible Assets
41,107.00
-9.38%
45,362.00
-6.77%
48,654.00
-15.39%
57,504.00
Goodwill
21,754.00
+0.16%
21,719.00
+2.60%
21,169.00
+0.09%
21,149.00
Other Intangible Assets
19,353.00
-18.14%
23,643.00
-13.98%
27,485.00
-24.40%
36,355.00
Investments And Advances
2,507.00
-0.04%
2,508.00
+0.36%
2,499.00
+14.27%
2,187.00
Long Term Equity Investment
2,096.00
+20.74%
1,736.00
+2.18%
1,699.00
-22.31%
2,187.00
Non Current Accounts Receivable
—
—
436.00
—
Non Current Deferred Assets
5,378.00
+26.96%
4,236.00
+53.03%
2,768.00
+105.95%
1,344.00
Non Current Deferred Taxes Assets
5,378.00
+26.96%
4,236.00
+53.03%
2,768.00
+105.95%
1,344.00
Other Non Current Assets
2,201.00
+3.67%
2,123.00
+84.93%
1,148.00
+52.66%
752.00
Total Liabilities Net Minority Interest
71,532.00
-6.14%
76,215.00
+16.05%
65,674.00
-0.04%
65,702.00
Current Liabilities
23,417.00
-1.50%
23,774.00
+6.79%
22,262.00
+1.70%
21,890.00
Payables And Accrued Expenses
6,321.00
-9.00%
6,946.00
+12.18%
6,192.00
+12.60%
5,499.00
Payables
5,837.00
-8.42%
6,374.00
+9.09%
5,843.00
+12.84%
5,178.00
Accounts Payable
3,575.00
-0.75%
3,602.00
+10.52%
3,259.00
+7.20%
3,040.00
Dividends Payable
1,283.00
+1.99%
1,258.00
+3.71%
1,213.00
+1.42%
1,196.00
Current Accrued Expenses
484.00
-15.38%
572.00
+63.90%
349.00
+8.72%
321.00
Employee Benefits
330.00
-17.50%
400.00
-16.67%
480.00
+19.40%
402.00
Pensionand Other Post Retirement Benefit Plans Current
1,561.00
-7.85%
1,694.00
+31.22%
1,291.00
-9.40%
1,425.00
Total Tax Payable
979.00
-35.34%
1,514.00
+10.43%
1,371.00
+45.54%
942.00
Income Tax Payable
979.00
-35.34%
1,514.00
+10.43%
1,371.00
+45.54%
942.00
Current Debt And Capital Lease Obligation
2,463.00
+10.60%
2,227.00
-32.12%
3,281.00
-25.43%
4,400.00
Current Debt
2,261.00
+10.51%
2,046.00
-34.40%
3,119.00
-26.85%
4,264.00
Other Current Borrowings
2,261.00
+10.51%
2,046.00
-34.40%
3,119.00
-26.85%
4,264.00
Current Capital Lease Obligation
202.00
+11.60%
181.00
+11.73%
162.00
+19.12%
136.00
Other Current Liabilities
13,072.00
+1.28%
12,907.00
+12.25%
11,498.00
+8.82%
10,566.00
Total Non Current Liabilities Net Minority Interest
48,115.00
-8.25%
52,441.00
+20.80%
43,412.00
-0.91%
43,812.00
Long Term Debt And Capital Lease Obligation
44,676.00
-8.77%
48,973.00
+28.26%
38,183.00
+5.14%
36,317.00
Long Term Debt
42,850.00
-9.98%
47,603.00
+29.87%
36,653.00
+4.56%
35,056.00
Long Term Capital Lease Obligation
1,826.00
+33.28%
1,370.00
-10.46%
1,530.00
+21.33%
1,261.00
Defined Pension Benefit
330.00
+41.03%
234.00
-17.61%
284.00
-0.35%
285.00
Non Current Pension And Other Postretirement Benefit Plans
330.00
-17.50%
400.00
-16.67%
480.00
+19.40%
402.00
Tradeand Other Payables Non Current
1,407.00
-5.63%
1,491.00
-54.65%
3,288.00
-17.64%
3,992.00
Non Current Deferred Liabilities
878.00
-16.78%
1,055.00
-0.94%
1,065.00
-61.94%
2,798.00
Non Current Deferred Revenue
169.00
-26.52%
230.00
-23.33%
300.00
+6.01%
283.00
Non Current Deferred Taxes Liabilities
222.00
-39.84%
369.00
+9.17%
338.00
-84.40%
2,166.00
Other Non Current Liabilities
824.00
+57.85%
522.00
+31.82%
396.00
+30.69%
303.00
Stockholders Equity
18,473.00
+13.09%
16,335.00
-44.50%
29,430.00
-5.25%
31,061.00
Common Stock Equity
18,473.00
+13.09%
16,335.00
-44.50%
29,430.00
-5.25%
31,061.00
Capital Stock
292.00
+0.00%
292.00
+0.00%
292.00
+0.00%
292.00
Common Stock
292.00
+0.00%
292.00
+0.00%
292.00
+0.00%
292.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
2,922.75
-0.01%
2,923.00
+0.00%
2,923.00
+0.79%
2,900.00
Ordinary Shares Number
2,035.75
+0.33%
2,029.00
+0.40%
2,021.00
-2.60%
2,075.00
Treasury Shares Number
887.00
-0.78%
894.00
-0.89%
902.00
+9.33%
825.00
Additional Paid In Capital
46,387.00
+0.79%
46,024.00
+0.74%
45,684.00
+1.15%
45,165.00
Retained Earnings
16,896.00
+13.30%
14,912.00
-48.16%
28,766.00
+12.79%
25,503.00
Gains Losses Not Affecting Retained Earnings
-1,523.00
-23.02%
-1,238.00
+19.92%
-1,546.00
-20.69%
-1,281.00
Treasury Stock
43,579.00
-0.17%
43,655.00
-0.25%
43,766.00
+13.33%
38,618.00
Minority Interest
33.00
-37.74%
53.00
-3.64%
55.00
-3.51%
57.00
Other Equity Adjustments
40.00
-89.42%
378.00
+9350.00%
4.00
-98.28%
232.00
Total Equity Gross Minority Interest
18,506.00
+12.92%
16,388.00
-44.42%
29,485.00
-5.25%
31,118.00
Total Capitalization
61,323.00
-4.09%
63,938.00
-3.25%
66,083.00
-0.05%
66,117.00
Working Capital
5,973.00
-0.55%
6,006.00
-36.83%
9,508.00
+76.63%
5,383.00
Invested Capital
63,584.00
-3.64%
65,984.00
-4.65%
69,202.00
-1.68%
70,381.00
Total Debt
47,139.00
-7.93%
51,200.00
+23.48%
41,464.00
+1.83%
40,717.00
Net Debt
34,902.00
-11.20%
39,303.00
+38.84%
28,308.00
-6.26%
30,197.00
Capital Lease Obligations
2,028.00
+30.75%
1,551.00
-8.33%
1,692.00
+21.12%
1,397.00
Net Tangible Assets
-22,634.00
+22.02%
-29,027.00
-50.99%
-19,224.00
+27.30%
-26,443.00
Tangible Book Value
-22,634.00
+22.02%
-29,027.00
-50.99%
-19,224.00
+27.30%
-26,443.00
Available For Sale Securities
396.00
+23.75%
320.00
-12.09%
364.00
—
Foreign Currency Translation Adjustments
-997.00
-3.00%
-968.00
-19.21%
-812.00
+8.76%
-890.00
Held To Maturity Securities
15.00
-96.68%
452.00
+3.67%
436.00
0.00
Interest Payable
484.00
-15.38%
572.00
+63.90%
349.00
+8.72%
321.00
Investmentin Financial Assets
411.00
-46.76%
772.00
-3.50%
800.00
0.00
Minimum Pension Liabilities
-566.00
+12.65%
-648.00
+12.20%
-738.00
-18.46%
-623.00
Other Inventories
—
—
—
-484.00
Preferred Shares Number
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
14,156.00
-6.81%
15,190.00
+9.60%
13,860.00
+6.08%
13,066.00
Cash Flow From Continuing Operating Activities
14,156.00
-6.81%
15,190.00
+9.60%
13,860.00
+6.08%
13,066.00
Net Income From Continuing Operations
7,055.00
+178.98%
-8,933.00
-211.11%
8,040.00
+26.71%
6,345.00
Depreciation Amortization Depletion
4,011.00
-58.22%
9,600.00
-1.64%
9,760.00
-5.02%
10,276.00
Depreciation And Amortization
4,011.00
-58.22%
9,600.00
-1.64%
9,760.00
-5.02%
10,276.00
Other Non Cash Items
4,304.00
-68.04%
13,467.00
+1010.22%
1,213.00
+16.86%
1,038.00
Pension And Employee Benefit Expense
—
—
—
—
Stock Based Compensation
553.00
+9.07%
507.00
-2.12%
518.00
+13.35%
457.00
Asset Impairment Charge
1,098.00
-62.94%
2,963.00
+1061.96%
255.00
+42.46%
179.00
Deferred Tax
-965.00
+53.81%
-2,089.00
+36.47%
-3,288.00
-20.09%
-2,738.00
Deferred Income Tax
-965.00
+53.81%
-2,089.00
+36.47%
-3,288.00
-20.09%
-2,738.00
Operating Gains Losses
-1,445.00
-27.31%
-1,135.00
-56.77%
-724.00
-176.34%
-262.00
Change In Working Capital
-455.00
-156.17%
810.00
+142.32%
-1,914.00
+14.13%
-2,229.00
Change In Receivables
-295.00
-211.74%
264.00
+126.53%
-995.00
-50.08%
-663.00
Change In Inventory
-184.00
+62.14%
-486.00
+35.29%
-751.00
-988.41%
-69.00
Change In Payables And Accrued Expense
-6.00
+99.44%
-1,076.00
-165.68%
-405.00
+69.18%
-1,314.00
Change In Payable
-6.00
+99.44%
-1,076.00
-165.68%
-405.00
+69.18%
-1,314.00
Change In Account Payable
-2.00
-101.09%
184.00
-7.07%
198.00
+81.65%
109.00
Change In Other Working Capital
30.00
-98.58%
2,108.00
+789.45%
237.00
+229.51%
-183.00
Investing Cash Flow
-4,132.00
+80.65%
-21,352.00
-830.37%
-2,295.00
-116.10%
-1,062.00
Cash Flow From Continuing Investing Activities
-4,132.00
+80.65%
-21,352.00
-830.37%
-2,295.00
-116.10%
-1,062.00
Capital Expenditure
-1,311.00
-5.05%
-1,248.00
-3.23%
-1,209.00
-8.14%
-1,118.00
Capital Expenditure Reported
-1,311.00
-5.05%
-1,248.00
-3.23%
-1,209.00
-8.14%
-1,118.00
Net Investment Purchase And Sale
52.00
-91.59%
618.00
+174.82%
-826.00
-127.20%
3,037.00
Purchase Of Investment
-2,000.00
-160.08%
-769.00
+56.65%
-1,774.00
+50.61%
-3,592.00
Sale Of Investment
2,052.00
+47.95%
1,387.00
+46.31%
948.00
-85.70%
6,629.00
Net Business Purchase And Sale
-2,873.00
+86.14%
-20,722.00
-7870.00%
-260.00
+91.28%
-2,981.00
Purchase Of Business
-3,944.00
+81.93%
-21,821.00
-1766.64%
-1,169.00
+72.73%
-4,286.00
Gain Loss On Sale Of Business
-1,165.00
-4.11%
-1,119.00
-26.58%
-884.00
+16.84%
-1,063.00
Financing Cash Flow
-10,348.00
-301.83%
5,127.00
+154.45%
-9,416.00
+44.49%
-16,962.00
Cash Flow From Continuing Financing Activities
-10,348.00
-301.83%
5,127.00
+154.45%
-9,416.00
+44.49%
-16,962.00
Net Issuance Payments Of Debt
-5,175.00
-151.26%
10,096.00
+2114.04%
456.00
+108.59%
-5,311.00
Issuance Of Debt
5,765.00
-63.90%
15,969.00
+258.45%
4,455.00
-27.21%
6,120.00
Repayment Of Debt
-10,940.00
-86.28%
-5,873.00
-46.86%
-3,999.00
+65.02%
-11,431.00
Long Term Debt Issuance
5,740.00
-55.45%
12,883.00
+189.18%
4,455.00
-24.82%
5,926.00
Long Term Debt Payments
-10,940.00
-280.79%
-2,873.00
+25.93%
-3,879.00
+66.07%
-11,431.00
Net Long Term Debt Issuance
-5,200.00
-151.95%
10,010.00
+1637.85%
576.00
+110.46%
-5,505.00
Short Term Debt Issuance
25.00
-99.19%
3,086.00
0.00
-100.00%
194.00
Short Term Debt Payments
0.00
+100.00%
-3,000.00
-2400.00%
-120.00
0.00
Net Short Term Debt Issuance
25.00
-70.93%
86.00
+171.67%
-120.00
-161.86%
194.00
Net Common Stock Issuance
0.00
0.00
+100.00%
-5,155.00
+35.57%
-8,001.00
Common Stock Payments
0.00
0.00
+100.00%
-5,155.00
+35.57%
-8,001.00
Common Stock Dividend Paid
-5,045.00
-3.74%
-4,863.00
-2.51%
-4,744.00
-2.37%
-4,634.00
Cash Dividends Paid
-5,045.00
-3.74%
-4,863.00
-2.51%
-4,744.00
-2.37%
-4,634.00
Repurchase Of Capital Stock
0.00
0.00
+100.00%
-5,155.00
+35.57%
-8,001.00
Proceeds From Stock Option Exercised
-128.00
-20.75%
-106.00
-492.59%
27.00
-97.26%
984.00
Net Other Financing Charges
—
—
—
—
Changes In Cash
-324.00
+68.70%
-1,035.00
-148.16%
2,149.00
+143.34%
-4,958.00
Effect Of Exchange Rate Changes
195.00
+242.34%
-137.00
-404.44%
45.00
+236.36%
-33.00
Beginning Cash Position
10,347.00
-10.17%
11,519.00
+23.53%
9,325.00
-34.86%
14,316.00
End Cash Position
10,218.00
-1.25%
10,347.00
-10.17%
11,519.00
+23.53%
9,325.00
Free Cash Flow
12,845.00
-7.87%
13,942.00
+10.20%
12,651.00
+5.88%
11,948.00
Change In Income Tax Payable
-4.00
+99.68%
-1,260.00
-108.96%
-603.00
+57.62%
-1,423.00
Change In Tax Payable
-4.00
+99.68%
-1,260.00
-108.96%
-603.00
+57.62%
-1,423.00
Earnings Losses From Equity Investments
-280.00
-1650.00%
-16.00
-110.00%
160.00
-80.02%
801.00
Sale Of Business
1,071.00
-2.55%
1,099.00
+20.90%
909.00
-30.34%
1,305.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category